Literature DB >> 17466729

Is stair climb power a clinically relevant measure of leg power impairments in at-risk older adults?

Jonathan F Bean1, Dan K Kiely, Sharon LaRose, Joda Alian, Walter R Frontera.   

Abstract

OBJECTIVE: To test the clinical relevance of the stair climb power test (SCPT) as a measure of leg power impairments in mobility-limited older adults.
DESIGN: Cross-sectional analysis of baseline data from participants within a randomized controlled trial.
SETTING: Rehabilitation research gym. PARTICIPANTS: Community-dwelling older adults (N=138; mean age, 75.4 y) with mobility limitations as defined by the Short Physical Performance Battery (SPPB).
INTERVENTIONS: Not applicable. MAIN OUTCOME MEASURES: Leg power measures included the SCPT and double leg press power measured at 40% (DLP40) and 70% (DLP70) of the 1 repetition maximum. Mobility performance tests included the SPPB and its 3 components: gait speed, chair stand time, and standing balance.
RESULTS: Stair climb power per kilogram (SCP/kg) had correlations of moderate strength (r=.47, r=.52) with DLP40/kg and DLP70/kg, respectively. All 3 leg power measures correlated with each of the mobility performance measures with the exception of DLP40/kg (r=.11, P=.27) and DLP70/kg (r=.11, P=.18) with standing balance. Magnitudes of association, as described by the Pearson correlation coefficient, did not differ substantively among the separate power measures as they related to SPPB performance overall. Separate adjusted multivariate models evaluating the relationship between leg power and SPPB performance were all statistically significant and described equivalent amounts of the total variance (R(2)) in SPPB performance (SCP/kg, R(2)=.30; DLP40, R(2)=.32; DLP70, R(2)=.31). Analyses of the components of the SPPB show that the SCPT had stronger associations than the other leg power impairment measures with models predicting chair stand (SCP/kg, R(2)=.25; DLP40, R(2)=.12; DLP70, R(2)=.13), whereas both types of leg press power testing had stronger associations with models predicting gait speed (SCP/kg, R(2)=.16; DLP40, R(2)=.34; DLP70, R(2)=.34). Stair climb power was the only power measure that was a significant component of models predicting standing balance (SCP/kg R(2)=.20).
CONCLUSIONS: The SCPT is a clinically relevant measure of leg power impairments. It is associated with more complex modes of testing leg power impairments and is meaningfully associated with mobility performance, making it suitable for clinical settings in which impairment-mobility relationships are of interest.

Entities:  

Mesh:

Year:  2007        PMID: 17466729     DOI: 10.1016/j.apmr.2007.02.004

Source DB:  PubMed          Journal:  Arch Phys Med Rehabil        ISSN: 0003-9993            Impact factor:   3.966


  78 in total

1.  Stair negotiation time in community-dwelling older adults: normative values and association with functional decline.

Authors:  Mooyeon Oh-Park; Cuiling Wang; Joe Verghese
Journal:  Arch Phys Med Rehabil       Date:  2011-12       Impact factor: 3.966

2.  Regional muscle and whole-body composition factors related to mobility in older individuals: a review.

Authors:  Jason Kidde; Robin Marcus; Lee Dibble; Sheldon Smith; Paul Lastayo
Journal:  Physiother Can       Date:  2009-11-12       Impact factor: 1.037

3.  Performance-based versus patient-reported physical function: what are the underlying predictors?

Authors:  Jonathan F Bean; Daniele D Olveczky; Dan K Kiely; Sharon I LaRose; Alan M Jette
Journal:  Phys Ther       Date:  2011-10-14

4.  Association between ankle muscle strength and limit of stability in older adults.

Authors:  Itshak Melzer; Nissim Benjuya; Jacob Kaplanski; Neil Alexander
Journal:  Age Ageing       Date:  2008-11-22       Impact factor: 10.668

5.  Development and validation of a short portable sarcopenia measure in the African American health project.

Authors:  Douglas K Miller; Theodore K Malmstrom; Elena M Andresen; J Philip Miller; Margaret M Herning; Mario Schootman; Fredric D Wolinsky
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2009-01-30       Impact factor: 6.053

6.  Power training in patients with knee osteoarthritis: a pilot study on feasibility and efficacy.

Authors:  Denis Pelletier; Cédric Gingras-Hill; Patrick Boissy
Journal:  Physiother Can       Date:  2013       Impact factor: 1.037

7.  Effects of enobosarm on muscle wasting and physical function in patients with cancer: a double-blind, randomised controlled phase 2 trial.

Authors:  Adrian S Dobs; Ralph V Boccia; Christopher C Croot; Nashat Y Gabrail; James T Dalton; Michael L Hancock; Mary A Johnston; Mitchell S Steiner
Journal:  Lancet Oncol       Date:  2013-03-14       Impact factor: 41.316

8.  Sarcopenia: European consensus on definition and diagnosis: Report of the European Working Group on Sarcopenia in Older People.

Authors:  Alfonso J Cruz-Jentoft; Jean Pierre Baeyens; Jürgen M Bauer; Yves Boirie; Tommy Cederholm; Francesco Landi; Finbarr C Martin; Jean-Pierre Michel; Yves Rolland; Stéphane M Schneider; Eva Topinková; Maurits Vandewoude; Mauro Zamboni
Journal:  Age Ageing       Date:  2010-04-13       Impact factor: 10.668

9.  An overview of sarcopenia: facts and numbers on prevalence and clinical impact.

Authors:  Stephan von Haehling; John E Morley; Stefan D Anker
Journal:  J Cachexia Sarcopenia Muscle       Date:  2010-12-17       Impact factor: 12.910

10.  Maximum recovery after knee replacement--the MARKER study rationale and protocol.

Authors:  Chung-Wei Christine Lin; Lyn March; Jack Crosbie; Ross Crawford; Stephen Graves; Justine Naylor; Alison Harmer; Stephen Jan; Kim Bennell; Ian Harris; David Parker; Helene Moffet; Marlene Fransen
Journal:  BMC Musculoskelet Disord       Date:  2009-06-17       Impact factor: 2.362

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.